Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: A randomized, parallel-group, non-inferiority trial

Authors:

Abstract
No abstract available
Funding Information
  • Shionogi
  • Mitsubishi Tanabe Pharma Corporation
  • Mochida Pharmaceutical Company

This publication has 37 references indexed in Scilit: